SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Makers " 2,388 found 🔀 AI-powered Shuffle
My MAHA Monday at the Great American State Fair | WSJ Politics Newsletter for June 30
Plus, the Supreme Court tells President Trump he can’t fire Lisa Cook, and why Jamie Dimon wants to finance missile makers
Wauwatosa business calls for lawmakers to save hemp
In November, most hemp in Wisconsin will be illegal. Wisconsin's estimated $700 million-dollar industry will shut down.
Georgia lawmakers give businesses a boost in court battles
A year after overhauling court rules to help companies avoid massive jury verdicts, Georgia legislators have made legal battles easier, shorter and cheaper for businesses.
Florida lawmakers help bring KIDS Act across House finish line
The online safety package boosts privacy protections for minors and still allows states to impose further restrictions.
Opinion | Protect the workers who protect our health
Massachusetts lawmakers should pass bipartisan workplace violence reforms before the legislative session ends.
ERISA’s Important but Limited Role in Health Care Cost Containment
Executive Summary Rising health care costs have brought renewed attention to the Employee Retirement Income Security Act of 1974 (ERISA) as policymakers and advocates look for new ways to address increasingly expensive employer-sponsored coverage. Leveraging requirements under ERISA appears attractive because other cost-containment efforts have had limited success, making the statute seem like a potential […]
Former McCarthy aide details Trump’s expletive-laden attacks on lawmakers and the wild fight to put McCarthy in office
Democrats wrestle with race, populism and ideology in clashes with lawmakers of color
The Democratic Party is confronting its long-standing dilemmas over identity and ideology as it wrestles with populist challengers in communities of color.
Democrats Wrestle With Race, Populism and Ideology in Clashes With Lawmakers of Color
WASHINGTON (AP) — After democratic socialist Claire Valdez defeated an establishment-backed candidate in New York's congressional primary last week, her elated supporters quickly turned their attention to a new target. “You're next!” they chanted when an image of House Democratic leader Hakeem ...
Patients can save thousands with drug coupons, but only if insurers honor them
Patients who rely on co-pay assistance from drugmakers are typically heavy users of health care for whom delays in treatment or worsening conditions can lead to higher costs, according to patient advocates.
If a Lyme disease vaccine gets approved, how would it go over? We asked hunters
Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?
California health insurance tax hike: Will your premiums increase?
A balance act: To help fund the safety net, lawmakers have voted through a health tax extension that could increase premium costs for Californians with private insurance.
Politics Unplugged Podcast: Headlines with Stacy Pearson and Marcus Dell’Artino
The Politics Unplugged panel breaks down a possible Arizona special session tied to ESA vouchers, union protections and ballot measures. The discussion centers on whether lawmakers could unwind late-night legislation that angered teachers, police and firefighters. They also examine Gov. Katie Hobbs’ political leverage and why both parties may have reasons to cut a deal. Later, the podcast turns to Trump tax cuts, Democratic Socialists, the White House reflecting pool controversy and the World Cup.
Lawmakers say White House demolition debris at East Potomac Park poses health risk
Democratic lawmakers are urging the Trump administration to remove demolition debris from East Potomac Park Golf Course, citing health concerns, while the administration says the site poses no public health risk.
Congress Revives SAFE Banking Bill For Cannabis Businesses
A bipartisan group of lawmakers has renewed the push to let banks serve state-legal cannabis businesses without fear of federal penalties.
Volkswagen reportedly planning to axe 100,000 jobs
Volkswagen, one of the world’s largest automakers, is reportedly planning to axe as many as 100,000 jobs over the next few years, representing 15% of its global workforce.
WATCH: House Democratic leaders hold hearing on fair elections and voting rights
House Minority Leader Hakeem Jeffries and Democratic lawmakers held a hearing Thursday on defending fair elections and voting rights.
Business Council deliberations continue with four bill drafts
Lawmakers on the Joint Appropriations Committee spent another day diving through the Wyoming Business Council’s dealings. This time, they also reviewed draft bills that would influence how the council operates.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
The Politics Hour: The big winners in MD's primary elections
Leading Democratic nominee for Montgomery County Executive Will Jawando talks about his message to voters, dark money, and data centers. Plus, Tara Jackson wins the Democratic nomination for Prince George's County State's Attorney and WAMU's Alex Koma on D.C. lawmakers greenlighting the budget.
Dunleavy vetoes some health and education increases approved by Alaska lawmakers
Alaska Gov. Mike Dunleavy canceled funding increases for a variety of state health and education programs on Wednesday, vetoing a combined $57.8 million in general-purpose money from state budget bills passed by the Legislature.
Two NC lawmakers, a Democrat and a Republican, push Congress to delay SNAP changes
Above the federal penalty threshold, NC could owe $140M a year, putting at risk a program that helps over 1.2 million North Carolinians.
Supreme Court protects pesticides from some health claims in key Roundup case
The Supreme Court on Thursday restricted Americans’ ability to sue pesticide makers over alleged health harms stemming from their products. In a 7-2 ruling, the court held that some claims that pes…
Memphis People in Business for June 25, 2026
A look at promotions, hirings, movers and newsmakers in the Memphis area business scene
Micron and Qualcomm forecasts ignite $400 billion AI chip stock rally
Shares of chipmakers surged late on Wednesday, adding over $400 billion in market value after strong forecasts from Micron Technology and Qualcomm breathed fresh life into Wall Street's recently waning AI stock rally.
Newsom visits SF Mexican restaurant for 1st meeting with Becerra
The two lawmakers chatted over a mid-morning meal on Wednesday.
IHSA reacts as lawmakers propose bill requiring oversight on girls' sports impact
A new bill in Springfield would seek to overturn an IHSA decision to change the girls' high school flag football season
Rand Paul questions USPS business model as postmaster general seeks reform
Kentucky Senator Rand Paul is questioning the United States Postal Office’s (USPS) business model following the appearance of the agency’s postmaster general before lawmakers.
Science Day 2026 at the HLPF: The science-policy imperative in the final stretch to 2030 and beyond
Science Day convenes scientists, policymakers and societal actors at the HLPF to examine science's role in accelerating SDG delivery to 2030.
UConn Business Researchers Discover Voluntary Corporate Climate Goals Are Viewed Favorably by Investors
'For company decisionmakers, there is clearly no argument for not considering it'
Buffalo Bills Should Still Target These 3 Playmakers for Josh Allen
Even with the NFL offseason coming close to an end, the Buffalo Bills should look to add one of these three playmakers for Josh Allen.
House gives final approval to bipartisan housing bill aimed at lowering costs
Lawmakers in both parties are eager to show progress on affordability issues ahead of this year’s midterm elections
Automakers could halt car sales in California without delay in vehicle tracking law
A group representing major automakers warned on Tuesday that car companies may be forced to halt sales of both new and used vehicles in California on July 1 unless the state delays vehicle technology rules that aim to prevent perpetrators of domestic violence from tracking survivors.
Lawmakers call for answers from Wyoming Business Council leader
After slashing the agency's budget, legislators examine the state's role in economic development.
NC students bring calls for school funding, mental health support to legislature
Students from across North Carolina urged lawmakers to invest more in public schools, citing concerns including mental health services
Sportico Studio’s New Video Experience Debuts at Cannes Lions
Sportico this week launched Sportico Studio, a dedicated content and creative solutions offering for brands looking to engage the sports business community. The studio, featured on a new video page on Sportico’s homepage, will leverage Sportico‘s unique position at the center of the sports business ecosystem, connecting brands with influential decision-makers across leagues, teams, media, …
Utilizing Toy Chest, Part III: How Ravensburger Connects Business Strategies with Philanthropy
Learn how Ravensburger North America, one of the world’s leading game and puzzle makers, partners with TTF’s Toy Chest to create meaningful impact for children in need and reinforce the company’s commitment to social responsibility.
Markets Recoil in Global Sell-Off Driven by Tech Stocks
Chipmakers led the way down in South Korea, where the main index crashed 10 percent. Stocks in Europe were lower and S&P 500 futures pointed to a sharp fall.
New tax rules for sports bettors, entrepreneurs and others proposed in NC
North Carolina lawmakers are considering dozens of changes to tax law that could affect industries and people around the state, the result of months of closed-door negotiations among GOP leaders.
Pentagon seeks $80 billion from Congress for Iran war
The Pentagon has told lawmakers it needs roughly $80 billion, mostly to cover the cost of the war in Iran
'You're picking who gets protected': Scientists raise concerns about beachfront hardened structures
The N.C. Coastal Resources Commission's Science Panel draft report was released as the state Senate is considering rolling back the long-standing ban on structures like seawalls and groins along the coast. The scientists warned policymakers to be cautious about changes.
Cloudflare teams up with big browsers to help websites tell welcome from unwelcome visitors
Makers of Chrome, Edge, Firefox back bot-fraud defense called Private Access Control Tokens
How This Common Painkiller Is Stopping Cancer From Spreading, Scientists Reveal - Futura-Sciences
Guess Who? The Painkiller Hiding a Secret Weapon Riddle: it’s in countless family medicine cabinets. It’s the go-to when fever or pain strikes. For more than half a century, scientists have known about its anticancer properties. Some even believe it might lower the risk of metastases—those are the little troublemakers...
A New Bill Would Ban Lawmakers From Betting on Politics and Elections in Prediction Markets
CNBC’s Emily Wilkins reported last week that House lawmakers have introduced legislation that would prohibit members of Congress, their spouses, and dependent children from placing wagers in prediction markets on political, policy, or election outcomes. “House lawmakers are just dropping a brand new bill that would ban lawmakers from making any bets in prediction markets ... A New Bill Would Ban Lawmakers From Betting on Politics and Elections in Prediction Markets
Asheville film event to spotlight mental health, raise funds for counseling services
Filmmakers from across the Carolinas will be taking stage in Asheville as a regional film event aims to spark conversation about mental health.
‘Delay and deny’ insurance practices hinder health care, CT patients, doctors say
Local doctors, lawmakers, patients and the American Medical Association, say that the number of prior authorizations and claim denials that insurance companies issue is worsening.
5 Companies That Make Classic Car Bodies When The Automakers Won't
Some of the companies that build bodies for classic cars when the manufacturer won't include GTO Engineering, Superformance, and Real Deal Steel.
California braces for one of the biggest tax hikes in the last decade
California lawmakers and the governor this year are preparing to implement major tax hikes in a matter of weeks, representing one of the largest tax increases in the state within the last decade.
California state workers union warns of mass exodus with Newsom’s return to office order
California state workers are challenging a new mandate requiring them to return to the office four days a week starting July 1, as lawmakers advance a bill to ensure telework options.
California Politics 360 full episode | Lawmakers approve two major tax increases
This is a piece of the overall state spending plan, which the governor and legislature are expected to finalize by the end of the month.
Bigger, fewer, tougher: the new era of China-US biotech partnerships
China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.
Week in Politics: U.S.-Israel ties; Trump and Vance oppose ceasefire critics
President Trump and his vice-president pushed back against critics of the agreement to extend the ceasefire with Iran. Some Republican lawmakers have found the agreement wanting.
Midstate man shares near death experience after health insurance coverage denial
DOVER, Pa. (WHTM) — State lawmakers want to criminalize health insurance companies when their decision to deny coverage seriously injures or kills a patient. A York County man is doing much b…
Alogic Debuts New Touchscreen Monitors and Portable Displays With Mac Support
Alogic this week unveiled a new lineup of touchscreen displays that bring touch and stylus functionality to Macs, including the FOKUS interactive touchscreen series, the Aspekt Touch 27" monitor, and new Folio portable touchscreen displays. Aspekt Touch 27" While Apple has yet to release a touchscreen Mac, Alogic has established itself as one of the few display makers offering touch-enabled monitors designed to work with macOS.
New Mexico lawmakers press Presbyterian Health Plan over changes
"When the need is great but the money’s not, there’s an exodus," said Rep. Patricia Roybal Caballero, D-Albuquerque.
Senate panel advances college sports bill that SEC, Tuberville opposes
Bipartisan college sports legislation passed a key hurdle Thursday, but the SEC and some lawmakers still oppose the bill.
NC science panel urges caution in use of hardened structures to protect coastline
As state lawmakers consider repealing the longstanding ban on jetties on North Carolina’s coastline, some of the state’s top scientists are recommending "a cautious approach" to allowing any new hardened structures.
Molineux Stadium to host networking event
About 350 business owners, entrepreneurs and decision makers are expected to attend the event.
Meta lobbies Congress for immunity from lawsuits alleging online harm to children
Meta reportedly lobbied U.S. lawmakers for legal immunity from child harm lawsuits as part of the Kids Online Safety Act under Senate consideration.
AI is turning Nintendo and Sony products into accidental luxury goods
With component-makers busy supplying data centres, console prices are rising as demand outstrips production capacity
Ron Howard and Brian Grazer on 'Grinch' Sequel, YouTube Filmmakers
The Imagine Entertainment partners sat down with THR editor-in-chief Maer Roshan for a keynote conversation at the UCLA Entertainment Symposium, where they also touched on AI fears and their (lack of) retirement plans.
Exclusive | Pentagon Tells Lawmakers It Needs $80 Billion for Iran War and Other Bills
Military officials say the services could run out of money for operations this summer unless Congress passes a new wartime spending bill.
12-year-old shares journey with sickle cell anemia on Capitol Hill
A 12-year-old takes his story to Washington, D.C., sharing with lawmakers how specialized treatment transformed his life with sickle cell disease.
NJ Senate approves penalties for political violence
After a series of high-profile political killings rocked the nation, New Jersey lawmakers seek to heighten penalties for political violence.
MoU’s $300bn Iran reconstruction fund becomes US political flashpoint
Trump says US will not pay for planned fund as part of Iran MoU, as lawmakers connect price tag to affordability issues.
Steil pushes bill to ban lawmakers from political prediction markets - Live Updates
The Wisconsin Republican's legislation follows a string of high-profile episodes of alleged insider trading on the new markets.
Bipartisan Senate duo looks to help more small businesses sell goods overseas
A bipartisan pair of lawmakers, Sens. Angela Alsobrooks (D-Md.) and Dave McCormick (R-Pa.), will introduce a bill Thursday aimed at helping American small businesses get loans to export their goods…
National Science Foundation reverses decision to dismantle oceans-monitoring network after outcry
The Trump administration has reversed a plan to dismantle a sprawling ocean monitoring network after vigorous objections from Democratic lawmakers and scientists.
National Science Foundation halts plans to dismantle oceans observatory project
The Trump administration has reversed a plan to dismantle a sprawling ocean monitoring network after vigorous objections from Democratic lawmakers and scientists.
Legislation Overhauling College Sports Faces Major Test In The Senate
A bipartisan bill top lawmakers and athletic leaders have described as the best chance to stabilize college sports is facing a key test in the Senate.
College sports bill clears key Senate hurdle despite SEC, Big Ten opposition
WASHINGTON (AP) — A bill that top lawmakers and athletic leaders have described as the best chance to stabilize college sports cleared a key vote in the Senate on Thursday with bipartisan support after weeks of input from schools, conferences and athletes.
House lawmakers tuck into budget a $36K raise for longtime Boston politician
Ways and Means Committee Chair Aaron Michlewitz says it's to keep the $156,000 pay "competitive" for Suffolk register of deeds. But the Legislature also wants to consider consolidating registries across the state.
Legislation overhauling college sports faces Senate test
A bipartisan bill top lawmakers and athletic leaders have described as the best chance to stabilize college sports is facing a key test in the Senate.
Legislation overhauling college sports faces a major test in the Senate
A bipartisan bill top lawmakers and athletic leaders have described as the best chance to stabilize college sports is facing a key test in the Senate.
Memphis People in Business for June 18, 2026
A look at promotions, hirings, movers and newsmakers in the Memphis area business scene
California lawmakers to vote on tax increases affecting health insurance and digital software
California lawmakers are set to vote tomorrow on two tax increases, including higher taxes on health plans and a new sales tax on digital software, which are expected to raise billions annually for state programs.
Georgia GOP drops redistricting plan that would hurt Black representation
Gov. Brian Kemp had called a special session so Republicans could secure one or more additional House seats in the 2028 elections. But lawmakers pulled the plug.
Midterms 2026: Science Appropriators Up for Reelection
Some of the most important decision-makers in science policy are facing voters in primaries and general elections this year.
Michigan Lawmakers Take Up Bill To Cap Marijuana Business Licenses As Industry Reels From Tax Increase
“We are doing our best to create the right regulatory scheme to be able to adequately enforce the market.” By Ben Solis, Michigan Advance The Michigan Senate is refocusing its marijuana industry license cap legislation to include new barriers to obtaining a license for growers, processors or dispensary operators with outstanding industry-related tax debt—a move […]
Thwarted attack on UFC fight is another reason to build White House ballroom, Trump DOJ argues
Federal courts have looked skeptically at President Donald Trump’s assertion that he can construct a massive new ballroom without approval from lawmakers
Georgia Republicans backtrack on redistricting plans
After Gov. Brian Kemp called them into a special session, state lawmakers said they didn’t have enough time to draw new maps that would have taken effect for the 2028 elections.
Health services deal value holds steady in 2026 with higher bar for investment: PwC
The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report | The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report from PwC.
From YouTube to Hollywood: Digital creators are remaking the movie business
Some of the most promising young filmmakers in the movie business are arriving in Hollywood already experts at entertaining audiences and going viral. The twin sensations of “Obsession” and “Backrooms”
How the fight over US datacenters is scrambling this state’s politics: ‘We don’t want it’
Josh Shapiro, Pennsylvania’s governor, squares off with state lawmakers over the facilities powering an AI boom
Political contribution limits in Oregon take effect in January — but it’s unclear if election officials will
Three months after lawmakers provided more guidance and funding for the law's rollout, there are still several major unknowns.
Toward a uniform business tax system: Examining proposals to tax large pass-through entities as corporations
In a new paper for the Hamilton Project, we examine an approach that many policymakers have offered to reform pass-through taxation: requiring large or complex pass-through entities to pay federal income tax at the entity level, as corporations do.
Ohio bill would ban use of politicians’ names, images on publicly funded signage
COLUMBUS, Ohio (WCMH) – Two Ohio lawmakers are attempting to ban the use of taxpayer dollars for political branding on public signage, such as road signs. Reps. Mark Hiner (R-Howard) and Tex …
Senate Republicans want a say on Trump’s Iran deal
Lawmakers said they are eager to delve into the fine print, though there is a high bar to overturning any final agreement.
OPCW and UNODA partner to bridge gap between scientists and policymakers
Scientists learn how to apply policy and diplomacy at OPCW-UNODA workshop on chemical and biological disarmament
Missouri Sen. Eric Schmitt pushes federal fix for college sports amid NIL chaos
Missouri Sen. Eric Schmitt is among lawmakers pushing federal legislation aimed at creating uniform rules for college athletics as lawsuits make it harder for the NCAA to enforce basic regulations.
Massachusetts looks for ‘happy medium’ on swipe fee reforms
Mass. lawmakers are hoping that business groups, banks, credit card companies, and payment processors will help them cut a path through the thicket of credit card swipe fees.
Lawmakers fight to stop the Trump administration's dismantling of a $386 million ocean observatory project
Monday’s pushback against the Republican administration’s actions comes as scientists are set to remove instruments from the Pacific and as an El Niño event is predicted to arrive this summer.
Local lawmakers ask small business admin for Tijuana River Valley support
Members of San Diego's congressional delegation Monday called on the U.S. Small Business Administration to continue to support small businesses impacted by Tijuana River Valley pollution.
Business Monday: New small business network offers support for aspiring entrepreneurs on the Big Island
The new network seeks to cultivate local businesses grounded in cultural values and shared prosperity through mentorship, funding and resources.
One year after her death, lawmakers reflect on former House Speaker Melissa Hortman's legacy at the Legislature
Lawmakers across the political spectrum say what best defines Hortman's legacy in St. Paul is that she consistently put people above politics.
Senate Republican on FISA holdup: ‘Stop playing the politics’
Sen. Shelley Moore Capito (R-W.V.) on Sunday slammed her fellow lawmakers after both chambers of Congress failed to pass bills to extend Section 702 of the Foreign Intelligence Surveillance Act (FI…
Georgia's vote-counting method will soon be banned. Lawmakers will try to find a fix this week
Legislators passed a law two years ago barring the use of the QR code printed on ballots that the state relies on to tally votes beyond July 1 of this year, but no replacement method was ever implemented.
On the brink: Black lawmakers could lose decades of gains in one year
The US is on the brink of the largest reduction in Black representation in Congress since the enactment of the Voting Rights Act almost 61 years ago.
Mapped: Where data centers are facing bans and moratoriums
Many Americans are resisting data centers across the country. Now, some lawmakers are responding with temporary moratoriums and outright bans.
Dooley campaigns with Kemp in Middle Georgia as lawmakers allege 'pay-to-play politics'
Derek Dooley is making some of his final pitches to voters in Middle Georgia as the U.S. Senate runoff inches closer to Election Day, and his campaign faces...